1 completed, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow polysaccharide-K: new trials by email Literature Review of polysaccharide-K trials Research Report on polysaccharide-K
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy HER-2/neu Intracellular Domain Protein, Laboratory Biomarker Analysis, Pertuzumab - HER2/Neu Positive, Recurrent Breast Carcinoma | Phase 1 / Phase 2 | Completed | University of Washington | 31 | 2014-02-05 | 2023-04-18 |
| A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer Docetaxel, PSK®, Docetaxel, Placebo - Prostatic Neoplasms | Phase 1 | Withdrawn | Bastyr University | 2013-05-01 | 2015-10-27 |
Adenocarcinoma (1) · Breast Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Prostatic Neoplasms (1)
Bastyr University (1) · University of Washington (1)
United States (2)
Celestia Higano, MD (1) · Cynthia A Wenner, Ph.D (1) · Leanna J Standish, PhD, ND, LAc (1) · Lupe Salazar (1)
P30CA015704 (1), U19AT006028 (1)